Skip to Main Content

Paper Details

Pilot neoadjuvant trial in HER2 positive breast cancer with combination of nab-paclitaxel and lapatinib.
Breast Cancer Res Treat
26
2012
EGFR, HER2, HER2 positive breast cancer, Lapatinib, anthracycline, bone pain, epidermal growth factor receptor, fatigue, human, human epidermal receptor two, lapatinib, nab, neuropathy, paclitaxel, patients, rash, women

Datasets